Clinicopathological characteristics of patients who underwent total thyroidectomy for treatment of differentiated thyroid cancer between 2012 and 2017
| Characteristic | No. (%) of patients* n = 147 |
|---|---|
| Sex | |
| Female | 107 (72.8 ) |
| Male | 40 (27.2) |
| Age, mean ± SD, yr | 47.8 ± 14.5 |
| Age, yr | |
| < 40 | 47 (32.0) |
| ≥ 40 | 100 (68.0) |
| Papillary carcinoma | 139 (94.6) |
| Follicular carcinoma | 8 (5.4) |
| Central lymph node dissection† | 84 (57.1) |
| Time to RAIU follow-up, mean ± SD, d | 95 ± 68 |
| Time to postoperative thyroglobulin measurement, mean ± SD, d | 75 ± 37 |
| Nodal yield (n = 84) | |
| < 2 | 14 (16.7) |
| ≥ 3 | 70 (83.3) |
| No. of nodes, mean ± SD | 7.1 ± 6.6 |
| Radioactive iodine administered postoperatively | 115 (78.2) |
| Postoperative serum thyroglobulin level, mean ± SD, μg/L | 4.3 ± 10.4 |
| Postoperative 24-h RAIU, mean ± SD, % | 2.1 ± 3.8 |
| MLNR, mean ± SD (n = 70) | 0.33 ± 0.33 |
| MACIS prognostic score, mean ± SD | 5.0 ± 1.5 |
| MACIS prognostic score | |
| Group 1 (< 6.00) | 118 (80.3) |
| Group 2 (6.00–6.99) | 14 (9.5) |
| Group 3 (7.00–7.99) | 10 (6.8) |
| Group 4 (≥ 8.00) | 5 (3.4) |